Condition
Brain Development Abnormality
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Terminated1
Active Not Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT03977259Not ApplicableActive Not Recruiting
Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development
NCT03410810Recruiting
Childhood Outcomes of Preterm Brain Abnormalities
NCT05564845UnknownPrimary
Brain Structure and Neurocognitive Development in Sickle Cell Disease; a Longitudinal Cohort Study (BRICK Study)
NCT03494855Terminated
Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations
Showing all 4 trials